IGF-binding protein-2 protects against the development of obesity and insulin resistance

Diabetes

Volumn 56, Issue 2, 2007, Pages 285-294

  Wheatcroft, Stephen B ^a   Kearney, Mark T ^a   Shah, Ajay M ^b   Ezzat, Vivienne A ^b   Miell, John R ^b   Modo, Michael ^b   Williams, Stephen C R ^b   Cawthorn, Will P ^c   Medina Gomez, Gema ^c   Vidal Puig, Antonio ^c   Sethi, Jaswinder K ^c   Crossey, Paul A ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GLUCOSE; LEPTIN;

ADIPOGENESIS; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENERGY; FEEDING; FEMALE; GENE OVEREXPRESSION; GLUCOSE INTOLERANCE; IN VITRO STUDY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; TRANSGENIC MOUSE; WILD TYPE;

3T3-L1 CELLS; ADIPOCYTES; ADIPOSITY; AGING; ANIMALS; BLOOD PRESSURE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FATTY LIVER; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MICE; MICE, TRANSGENIC; OBESITY; PHENOTYPE; THINNESS;

EID: 33847045938     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-0436     Document Type: Article

References (38)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL: Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288:1723-1727, 2002
2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB: Years of life lost due to obesity. JAMA 289:187-193, 2003
3. Gregoire FM, Smas CM, Sul HS: Understanding adipocyte differentiation. Physiol Rev 78:783-809, 1998
4. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ: The biology of white adipocyte proliferation. Obes Rev 2:239-254, 2001
5. Schmidt W, Poll-Jordan G, Loffler G: Adipose conversion of 3T3-L1 cells in a serum-free culture system depends on epidermal growth factor, insulinlike growth factor I, corticosterone, and cyclic AMP. J Biol Chem 265:15489-15495, 1990
6. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS: Insulin-like growth factor-I is an essential regulator of the differentiation of 3T3-L1 adipocytes. J Biol Chem 263:9402-9408, 1988
7. Deslex S, Negrel R, Ailhaud G: Development of a chemically defined serum-free medium for differentiation of rat adipose precursor cells. Exp Cell Res 168:15-30, 1987
8. Nougues J, Reyne Y, Barenton B, Chery T, Garandel V, Soriano J: Differentiation of adipocyte precursors in a serum-free medium is influenced by glucocorticoids and endogenously produced insulin-like growth factor-I. Int J Obes Relat Metab Disord 17:159-167, 1993
9. Ramsay TG, White ME, Wolverton CK: Insulin-like growth factor 1 induction of differentiation of porcine preadipocytes. J Anim Sci 67:2452-2459, 1989
10. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson DM, Rosenfeld RG: Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 28:619-637, 1996
11. Firth SM, Baxter RC: Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854, 2002
12. Crossey PA, Jones JS, Miell JP: Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49:457-465, 2000
13. Crossey PA, Pillai CC, Miell JP: Altered placental development and intrauterine growth restriction in IGF binding protein-1 transgenic mice. J Clin Invest 110:411-418, 2002
14. Wheatcroft SB, Kearney MT, Shah AM, Grieve DJ, Williams IL, Miell JP, Crossey PA: Vascular endothelial function and blood pressure homeostasis in mice overexpressing IGF binding protein-1. Diabetes 52:2075-2082, 2003
15. Siddals KW, Westwood M, Gibson JM, White A: IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte. J Endocrinol 174:289-297, 2002
16. Rajkumar K, Modric T, Murphy LJ: Impaired adipogenesis in insulin-like growth factor binding protein-1 transgenic mice. J Endocrinol 162:457-465, 1999
17. Boney CM, Moats-Staats BM, Stiles AD, D'Ercole AJ: Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology 135:1863-1868, 1994
18. Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H: Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabete Metab Res Rev 15:314-322, 1999
19. Ehrenborg E, Vilhelmsdotter S, Bajalica S, Larsson C, Stern I, Koch J, Brondum-Nielsen K, Luthman H: Structure and localization of the human insulin-like growth factor-binding protein 2 gene. Biochem Biophys Res Commun 176:1250-1255, 1991
20. Wheatcroft SB, Shah AM, Li JM, Duncan E, Noronha BT, Crossey PA, Kearney MT: Preserved glucoregulation but attenuation of the vascular actions of insulin in mice heterozygous for knockout of the insulin receptor. Diabetes 53:2645-2652, 2004
21. Sethi JK, Xu H, Uysal KT, Wiesbrock SM, Scheja L, Hotamisligil GS: Characterisation of receptor-specific TNFalpha functions in adipocyte cell lines lacking type 1 and 2 TNF receptors. FEBS Lett 469:77-82, 2000
22. Jitrapakdee S, Slawik M, Medina-Gomez G, Campbell M, Wallace JC, Sethi JK, O'Rahilly S, Vidal-Puig AJ: The peroxisome proliferator-activated receptor-{gamma} regulates murine pyruvate carboxylase gene expression in vivo and in vitro. J Biol Chem 280:27466-27476, 2005
23. Prins JB, O'Rahilly S: Regulation of adipose cell number in man. Clin Sci (Lond) 92:3-11, 1997
24. Yakar S, Wu Y, Setser J, Rosen CJ: The role of circulating IGF-I: lessons from human and animal models. Endocrine 19:239-248, 2002
25. Doglio A, Dani C, Fredrikson G, Grimaldi P, Ailhaud G: Acute regulation of insulin-like growth factor-I gene expression by growth hormone during adipose cell differentiation. EMBO J 6:4011-4016, 1987
26. O'Brien SF, Russell JC, Davidge ST: Modulation of vasomotion in resistance arteries of JCR:LA-cp rats: a model of insulin resistance. Can J Physiol Pharmacol 77:71-74, 1999
27. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A: Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72, 1993
28. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D: Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96:7324-7329, 1999
29. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C: Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088-7092, 1999
30. Sjogren K, Wallenius K, Liu JL, Bohlooly YM, Pacini G, Svensson L, Tornell J, Isaksson OG, Ahren B, Jansson JO, Ohlsson C: Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50:1539-1545, 2001
31. Duan C: Specifying the cellular responses to IGF signals: roles of IGF-binding proteins. J Endocrinol 175:41-54, 2002
32. Hoeflich A, Wu M, Mohan S, Foll J, Wanke R, Froehlich T, Arnold GJ, Lahm H, Kolb HJ, Wolf E: Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140:5488-5496, 1999
33. Modric T, Silha JV, Shi Z, Gui Y, Suwanichkul A, Durham SK, Powell DR, Murphy LJ: Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 142:1958-1967, 2001
34. Salih DA, Tripathi G, Holding C, Szestak TA, Gonzalez MI, Carter EJ, Cobb LJ, Eisemann JE, Pell JM: Insulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in mice. Proc Natl Acad Sci U S A 101:4314-4319, 2004
35. Bienvenu G, Seurin D, Grellier P, Froment P, Baudrimont M, Monget P, Le Bouc Y, Babajko S: Insulin-like growth factor binding protein-6 transgenic mice: postnatal growth, brain development, and reproduction abnormalities. Endocrinology 145:2412-2420, 2004
36. Wood TL, Rogler LE, Czick ME, Schuller AG, Pintar JE: Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. Mol Endocrinol 14:1472-1482, 2000
37. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556, 2004
38. Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, Gamel AE, Desai JB, Nelson T, Driver C, Sherwood RA, Kearney MT: Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur Heart J 27:2295-2299, 2006